Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-061528
Filing Date
2022-10-04
Accepted
2022-10-04 06:01:36
Documents
6
Period of Report
2022-10-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea166698-6k_immuron.htm 6-K 13130
2 IMC - IMMURON EXECUTES TRAVELAN CLINICAL TRIAL AGREEMENT PHARMARON ea166698ex99-1_immuron.htm EX-99.1 20023
3 GRAPHIC image_001.jpg GRAPHIC 2744
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5266
5 GRAPHIC ex99-1_002.jpg GRAPHIC 6784
6 GRAPHIC ex99-1_003.jpg GRAPHIC 3294
  Complete submission text file 0001213900-22-061528.txt   59636
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 221289651
SIC: 2834 Pharmaceutical Preparations